![]() To calculate Decibel Therapeutics's market, we take the total number of its shares issued and multiply it by Decibel Therapeutics's current market price. Market capitalization usually refers to the total value of a company's stock within the entire market. The company currently falls under 'Small-Cap' category with a current market capitalization of 106.56 M. Decibel Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification. It is located in 1325 Boylston Street, Boston, MA, United States, 02215 and employs 68 people. Operating Cash FlowÄecibel Therapeutics (DBTX) is traded on NASDAQ Exchange in USA. When we think about Decibel Therapeutics' use of debt, we should always consider it together with cash and equity. ![]() Debt, in this case, can be an excellent and much better tool for Decibel to invest in growth at high rates of return. However, a more frequent occurrence is when companies like Decibel Therapeutics sell additional shares at bargain prices, diluting existing shareholders. So, Decibel Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. Debt can assist Decibel Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. Decibel Therapeutics has a current ratio of 6.06, suggesting that it is liquid enough and is able to pay its financial obligations when due. The company currently holds 15.38 M in liabilities with Debt to Equity (D/E) ratio of 0.14, which may suggest the company is not taking enough advantage from borrowing. It can also help you figure out where your money is going and how much cash you have available at a given moment. Decibel Therapeutics cash flow analysis is essential to understand how it generates and spends money over a specific period.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |